Genome-Wide RNAi Screening Identifies Novel Host Factors Involved in Influenza A Virus Infection in A549 Cells

Area of Science:

• Virology
• Genomics
• Pharmacology

Background:

• Influenza A virus (IAV) poses a significant global health risk.
• Viral mutation and drug resistance necessitate novel therapeutic strategies like host-directed antivirals.

Purpose of the Study:

• To conduct a genome-wide siRNA screen to identify host genes affecting Influenza A virus (PR8/H1N1) infection.
• To discover host factors influencing viral replication and cell viability.

Main Methods:

• A genome-wide siRNA screen was performed in A549 cells using cell viability as the endpoint.
• Statistical analysis and pathway analysis (MetaCore, DAVID) were used to identify significant host genes and biological processes.
• The screen results were benchmarked against existing RNAi and CRISPR datasets and integrated with DrugBank.

Main Results:

• 2134 host genes showed significant changes in cell viability (>40%) upon IAV infection.
• Enriched pathways included RAS-related signaling, metabolic pathways (estradiol, ubiquinone/mitochondrial redox), and xenobiotic metabolism.
• 174 druggable host genes were identified, corresponding to 345 candidate compounds for potential drug repurposing.

Conclusions:

• This study provides a comprehensive resource of host factors impacting H1N1 infection.
• The findings enhance understanding of influenza virus-host interactions.
• The identified host factors and compounds lay the groundwork for developing novel host-directed antiviral therapies.